top of page
ARTICLES
Explore published articles and webinars from Litmys leaders that spotlight new thinking and practical approaches to achieving market success across the life sciences.


CAR-T Commercialization Lessons: Insights from the Yescarta Launch
What can the Yescarta launch teach today's life sciences leaders? Building on Harris Kaplan's In Vivo podcast, this article explores the CAR-T commercialization lessons that continue to shape launch strategy, market access, and real-world adoption.
Jul 211 min read


Harris Kaplan Featured on Citeline's In Vivo Podcast: The Yescarta Launch Examined
What determines whether a breakthrough therapy becomes a commercial success? In this Citeline In Vivo podcast, Harris Kaplan joins former Kite Pharma executive Diane Parks and CAR-T patient Jim Haag to discuss the launch of Yescarta and the critical role that stakeholder adoption, market access, and real-world implementation play in translating scientific innovation into lasting impact.
Jun 171 min read


Managing Partner, Harris Kaplan, published in In Vivo: Physician Behavioral Inertia - Innovation’s Greatest Enemy
Harris Kaplan , Managing Partner, just published an article in In Vivo, Physician Behavioral Inertia: Innovation’s Greatest Enemy ....
Sep 26, 20231 min read


Join us for Informa’s Newest Webinar – Transforming Cancer Treatment with Early Detection Diagnostics: Opportunities and Obstacles
We are pleased to announce that on October 22, Managing Partner, Harris Kaplan , will be joined by experts in the oncology field, where...
Oct 1, 20201 min read


Payer Power: What Are The Future Implications For Life Science Companies Developing New Products?
Harris Kaplan , Managing Partner, has partnered with Fred Dotzler to write the cover story for In Vivo January 2019. The article delves into what payers are doing in today’s world to try to control the cost of new life science products, and what steps they plan on taking to better control rising costs in the future. Payer Power: What Are The Future Implications For Life Science Companies Developing New Products?
Jan 16, 20191 min read
bottom of page